565: Routine antenatal fetal testing for women over 35 leads to increased intervention without apparent reduction in neonatal morbidity

Antenatal Corticosteroids to Reduce Neonatal Morbidity and Mortality

Antenatal Corticosteroids to Reduce Neonatal Morbidity and Mortality

Substance use of pregnant women and early neonatal morbidity: where to focus intervention?

BACKGROUND Few studies, and none in Canada, have examined the relation between maternal smoking, alcohol consumption and drug dependence during pregnancy and early neonatal morbidity. METHODS We analyzed records of singleton live births in Alberta, Canada. Markers of neonatal morbidity were Apgar scores (< 7 at 5 minutes postpartum) and resuscitation measures (2001-2005, N = 191,686), and neo...

Thrombophilic polymorphisms are common in women with fetal loss without apparent cause.

An association between fetal loss and thrombophilia has recently been described but has not been yet fully elucidated. We have evaluated prospectively the prevalence of the three common thrombophilic polymorphisms (TP) factor V G1691A (Leiden), thermolabile-methylenetetrahydrofolate reductase (TL-MTHFR) C677T and factor II G20210A mutations, in 76 women with fetal loss (> or =3 in first, > or =...

Acceptability of antenatal screening for depression in routine antenatal care.

OBJECTIVE The Edinburgh Postnatal Depression Scale (EPDS) is generally recognised as a valid, reliable, cost-effective and simple tool to implement within routine care, however there is controversy regarding the acceptability of screening for depression. This paper aims to examine how acceptable women find (1) completing a battery of questionnaires, including the EPDS and (2) receiving feedback...